Certified by Founder Lodge
Neurenati Therapeutics
Canada - Montréal, Québec
START UP
1 Disclosed Funding Rounds $1,200,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Neurenati develops novel therapies for GI rare diseases
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 01 ,2024 | Seed | $1,200,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
XCENA | $135,000,000 | (Jun 2, 2026)
Voxmind | $735,203 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
